上皮性卵巢癌幸存者的长期疲劳与生活质量:GINECO病例对照VIVROVAIRE I研究
该病例对照研究纳入法国25家GINECO中心的318例无复发≥3年的上皮性卵巢癌幸存者(EOCS)和318例年龄匹配健康对照,比较长期疲劳、症状及生活质量。EOCS整体生活质量与对照无差异,但疲劳评分更差(FACIT-F 40 vs 45,P<0.0001)、严重长期疲劳更多(26% vs 13%,P=0.0004),抑郁、神经毒性和睡眠障碍与严重长期疲劳相关。
要点
- EOCS与对照整体生活质量无差异,但FACIT-F疲劳评分更差(40 vs 45,P<0.0001)。
- EOCS严重长期疲劳比例更高(26% vs 13%,P=0.0004),睡眠质量更差(63% vs 47%,P=0.0003)。
- 多因素分析中抑郁、神经毒性和睡眠障碍与EOCS发生严重长期疲劳相关(P<0.01)。
核心结论
- 与对照相比,EOCS整体生活质量相似,但存在持续长期疲劳、EOC相关症状、神经毒性、抑郁和睡眠障碍。
- 抑郁、神经病变和睡眠障碍是与严重长期疲劳相关的主要情况。
研究设计与样本
- 病例对照研究,EOCS来自法国25家GINECO合作中心,对照从选民名册中随机选取。
- 共纳入318例EOCS和318例对照,EOCS为一线治疗后无复发≥3年者,对照为年龄匹配健康女性。
- 所有参与者完成经验证的自我报告问卷:疲劳(FACIT-F)、生活质量(FACT-G/O)、神经毒性(FACT-Ntx)、焦虑/抑郁(HADS)、睡眠障碍(ISI)和体力活动(IPAQ)。
- 严重长期疲劳(SLTF)定义为FACIT-F评分<37/52。
- 采用单因素和多因素逻辑回归分析EOCS中SLTF及其影响因素。
主要发现
- EOCS平均年龄63岁,FIGO I/II期占50%、III/IV期占48%;99%接受过铂类和紫杉类化疗,平均随访6年。
- 两组社会人口学特征和整体生活质量无差异。
- EOCS的FACIT-F评分更差(40 vs 45,P<0.0001),功能健康评分更低(18 vs 20,P=0.0002),FACT-O评分更差(31 vs 34,P<0.0001),FACT-Ntx评分更差(35 vs 39,P<0.0001)。
- EOCS报告更多SLTF(26% vs 13%,P=0.0004)、睡眠质量更差(63% vs 47%,P=0.0003)和更多抑郁(22% vs 13%,P=0.01)。
- EOCS和对照中定期锻炼者均少于20%。
关键数值与推荐
- SLTF定义为FACIT-F评分<37/52。
- EOCS的FACIT-F评分为40 vs 对照45(P<0.0001)。
- EOCS的SLTF发生率为26% vs 对照13%(P=0.0004)。
- EOCS的睡眠质量差比例为63% vs 对照47%(P=0.0003)。
- EOCS的抑郁比例为22% vs 对照13%(P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few data are available on long-term fatigue (LTF) and quality of life (QoL) among epithelial ovarian cancer survivors (EOCS). In this case-control study, we compared LTF, symptoms and several QoL domains in EOCS relapse-free ≥3 years after first-line treatment and age-matched healthy women. PATIENTS AND METHODS: EOCS were recruited from 25 cooperative GINECO centers in France. Controls were randomly selected from the electoral rolls. All participants completed validated self-reported questionnaires: fatigue (FACIT-F), QoL (FACT-G/O), neurotoxicity (FACT-Ntx), anxiety/depression (HADS), sleep disturbance (ISI), and physical activity (IPAQ). Severe LTF (SLTF) was defined as a FACIT-F score <37/52. Univariate and multivariate logistic regressions were conducted to analyze SLTF and its influencing factors in EOCS. RESULTS: A total of 318 EOCS and 318 controls were included. EOCS were 63-year-old on average, with FIGO stage I/II (50%), III/IV (48%); 99% had received platinum and taxane chemotherapy, with an average 6-year follow-up. There were no differences between the two groups in socio-demographic characteristics and global QoL. EOCS had poorer FACIT-F scores (40 versus 45, P < 0.0001), lower functional well-being scores (18 versus 20, P = 0.0002), poorer FACT-O scores (31 versus 34 P < 0.0001), and poorer FACT-Ntx scores (35 versus 39, P < 0.0001). They also reported more SLTF (26% versus 13%, P = 0.0004), poorer sleep quality (63% versus 47%, P = 0.0003), and more depression (22% versus 13%, P = 0.01). Fewer than 20% of EOCS and controls exercised regularly. In multivariate analyses, EOCS with high levels of depression, neurotoxicity, and sleep disturbance had an increased risk of developing SLTF (P < 0.01). CONCLUSION: Compared with controls, EOCS presented similar QoL but persistent LTF, EOC-related symptoms, neurotoxicity, depression, and sleep disturbance. Depression, neuropathy, and sleep disturbance are the main conditions associated with severe LTF.
引用
- Joly F, Ahmed-Lecheheb D, Kalbacher E, et al. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study. Ann Oncol. 2019. PMID: 30851097. doi:10.1093/annonc/mdz074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。